Imunon, Inc. (IMNN) vs Pulmatrix, Inc. (PULM)
- Imunon, Inc. IMNN 0.85 −5.56%
- Pulmatrix, Inc. PULM 1.39 −0.71%
Imunon, Inc. and Pulmatrix, Inc. are both Biotechnology companies. Imunon, Inc. and Pulmatrix, Inc. are of similar size ($5.1M and $5.1M). Pulmatrix, Inc. grew revenue faster over the last twelve months: 6.96% against 0.00%. Across the 15 metrics below, Pulmatrix, Inc. leads on 11 and Imunon, Inc. on 4.
Valuation
Profitability
| Metric | IMNN | PULM | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (641.02%) | (111.99%) | (51.96%) |
| Return on assets | (123.93%) | (85.74%) | (46.06%) |
| Return on invested capital | (324.37%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack